Corporate ActionJun 26, 2026, 04:13 PM
Context Therapeutics Stockholders Approve 50% Increase in Authorized Shares
AI Summary
Context Therapeutics Inc. held its Annual Meeting of Stockholders where shareholders approved an amendment to the company's Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 300,000,000. Additionally, seven director nominees were elected to the Board, and CohnReznick LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Key Highlights
- Stockholders approved increasing authorized common stock from 200,000,000 to 300,000,000 shares.
- The amendment to the Certificate of Incorporation was filed on June 24, 2026.
- Seven director nominees were elected to the Board of Directors.
- CohnReznick LLP was ratified as the independent registered public accounting firm for 2026.
- Approximately 79.27% of outstanding shares were present or represented at the meeting.
Price Impact
More from CNTX